Atlas Trials

Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

Clinical trial NCT07668856 · RECRUITING

Trial details

NCT number
NCT07668856
Sponsor
UMC Utrecht
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Refractory Epilepsy in ChildrenRefractory EpilepsyEpilepsy
Start date
2025-02-06
Primary completion
2027-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.